US07373V1052
US07373V1052
Beam Therapeutics Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 139.743.000 | 63.518.000 | 120.0% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 523.436.000 | 479.086.000 | 9.3% | |
| Operating Income | -383.693.000 | -415.568.000 | 7.7% |
| Pretax Income | -79.992.000 | -376.703.000 | 78.8% |
| Net Income Common Stockholders | -79.992.000 | -376.742.000 | 78.8% |
| -- | -- | -- | |
| -- | -- | -- |